logo
How the 'Big, Beautiful Bill' Could Affect Small Businesses

How the 'Big, Beautiful Bill' Could Affect Small Businesses

Entrepreneur21 hours ago
President Donald Trump's "Big, Beautiful Bill" is set to be voted on in the House on Thursday ahead of the President's July 4 deadline to pass the bill. (There's even a Domino's Pizza-style tracker on the White House website — "We are preparing your tax cuts..." it reads.)
The 887-page bill includes tax and spending cuts that will affect small businesses.
Related: Big Government Changes Are Coming for Small Businesses — What You Need to Know
On Fox News' "Mornings With Maria" on Wednesday, CPA and small business owner Gene Marks said the big winners of the bill "are small businesses."
"I think that's going to have an enormous impact on the growth of businesses in this country," Marks said. "There are certain tax provisions in this bill, investing in capital equipment, spending on research and development, [increasing] the exemption for estate taxes, [and] they've all been made permanent, which means that small businesses can make long-term decisions about investing in their businesses, selling their businesses, or passing it on to new generations knowing that the laws aren't going to change."
Ahead of the bill becoming law, here are some key items affecting businesses big and small:
Corporations
The tax breaks from the 2017 Tax Cuts and Jobs Act would be permanent when the bill passes, which allows businesses to write off the costs of research and development.
When the Ways and Means Committee voted to make the 2017 cuts permanent, they said that the provisions "will provide small businesses, manufacturers, and farmers the certainty and confidence to fuel a second Trump economic boom through new investment and job creation."
"Families and workers will save money from lower tax rates, a larger Child Tax Credit, and President Trump's tax priorities for hardworking Americans: tax relief for seniors, no tax on tips, no tax on overtime pay, and no tax on auto loan interest for American-made cars," the committee wrote on its website in May.
Building and construction
Businesses would be able to deduct the cost of building new manufacturing facilities in full and at a much faster rate. According to Associated Builders and Contractors (ABC), which represents 23,000 members and "millions" of construction workers, its website says, the legislation includes several tax provisions that will "directly benefit contractors."
"Tax certainty and pro-growth policies are not abstract policy goals for construction businesses—they are the foundation that allows ABC members to invest, grow, and keep America building," said Kristen Swearingen, ABC vice president of government affairs.
Franchises
The bill is backed by the International Franchise Association (IFA). President and CEO Matt Haller told Entrepreneur in June that the tax provisions in the bill "will have a hugely positive impact on America's 830,000 franchise small business owners and their nine million employees."
Related: Here's What the 'One, Big, Beautiful Bill' Means for the Franchise Industry
"IFA, our member brands and franchise owners have been laser-focused on ensuring permanent tax relief," Haller said. "IFA thanks President Trump for putting the importance of protecting franchise small business owners front and center, and lawmakers for their work to get this bill across the finish line."
Eliminates tax on tips
In occupations where workers receive tips (restaurants, bars, beauty services, etc.), earned tips will no longer be taxed as taxable income. There are a few caveats, though: The provision expires in 2028, and the deduction is capped at $25,000.
The exemption only applies to federal income tax, meaning state and local income and payroll taxes would not apply. Also, in the new Senate version of the bill, workers earning $150,000 or more a year ($300,000 for joint filers) are exempt.
No tax on overtime
White House estimates suggest that employees who work overtime hours would save up to $2,000 in taxes yearly with the bill.
"Exempting overtime pay from federal income tax delivers direct, meaningful relief to the hardworking men and women of the construction trades, rewarding long hours on the jobsite," the Associated Builders and Contractors said in a statement.
However, the AP reports that the bill does not eliminate taxes on Social Security benefits.
Interest deductions
If approved, the bill suggests that instead of calculating with EBIT (earnings before interest and taxes), deductions should be calculated using EBITDA (adds depreciation and amortization), which, the White House says, would allow businesses and franchises to deduct billions more in expenses.
State and local taxes (SALT) deductions
If the bill passes, the cap on the federal deduction for state and local taxes (SALT) will increase from $10,000 to $40,000 starting in 2025. According to the Tax Foundation, this will mainly benefit high earners.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Truist Lifts COPT Defense Properties (CDP) PT to $30
Truist Lifts COPT Defense Properties (CDP) PT to $30

Yahoo

time9 minutes ago

  • Yahoo

Truist Lifts COPT Defense Properties (CDP) PT to $30

COPT Defense Properties (NYSE:CDP) is one of the most undervalued stocks. On June 10, Truist maintained a Hold rating on CDP and raised the price target from $29 to $30. With a robust 4.31% yield, the company has consistently paid dividends for the past 34 years, indicating its commitment to shareholder returns. The target price update reflects a refined valuation approach that involves discounted cash flow analysis along with forecasted net asset value. Analysts reported that COPT Defense Properties (NYSE:CDP) is advancing three developments set to launch in 2025, with more projects on deck for 2026 and 2027. The $308 million active portfolio is 62% pre-leased, with 30% of the costs already invested. Occupancy at COPT Defense is forecasted to dip slightly to 91.9% by the end of 2025, compared to 92.3% in the first quarter. The firm also projects a low single-digit positive increase in GAAP rental spreads. A security guard patrolling a defense facility, protecting critical technologies. Analysts indicate that COPT Defense Properties (NYSE:CDP) is unlikely to engage in any mergers, acquisitions, or property disposals in 2025. However, they are factoring in a $400 million unsecured note issuance for the fourth quarter. COPT Defense, a self-managed REIT, focuses on the ownership, operation, and development of mission-critical real estate assets located near or within major US Government defense installations. While we acknowledge the potential of CDP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?
UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

Yahoo

time9 minutes ago

  • Yahoo

UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The rally has been powered by cooling inflation, resilient earnings, and fading tariff concerns after April's policy shock. Just three months back, the market briefly dipped toward bear territory amid geopolitical tensions, China's AI push, tariff fears, and fiscal uncertainty, keeping investors on edge about the rebound's staying power. Despite the S&P rallying over 28% from its April lows of $4,835, the bull run has still left many big names behind. Nearly a third of the index's stocks still ended the first half of 2025 in the red. UnitedHealth (UNH), a giant in health insurance and managed care services, has plunged 39% so far in 2025. UNH stock has been hit by soaring Medicare Advantage costs, a probe into Medicare fraud, and a sudden CEO exit, making it the index's fourth-worst performer. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Is Super Micro Computer Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! While UNH is at five-year lows, a 1.8% five-day bounce hints at some life. With the dividend-paying stock halved and trading at a compelling valuation, is this a classic 'buy the dip' setup? Or a moment for caution despite the allure of value and yield? Founded in 1977, UnitedHealth has grown into a $295 billion healthcare heavyweight. With its deep roots in health insurance and care services, the company runs on two powerhouse engines: UnitedHealthcare and Optum. UnitedHealthcare handles the insurance side, offering plans that serve over 50 million people. It's the backbone, giving the company scale, reach, and reliable revenue. But it's Optum that brings the spark, driving growth through data, tech, and pharmacy solutions. From analytics to care delivery, Optum's strategy pushes innovation across the system. Together, these segments give the company its edge in a complex healthcare landscape. UNH stock has been in free fall in 2025, hitting a low of $248.88 in May. Over the past 52 weeks, the stock has declined 38%, trailing far behind the broader S&P's surge of 13%. However, UNH stock is rebounding, up 1% over the past month. UnitedHealth's downfall in 2025 was not just a single bad headline. It was a chain reaction that started fast and spiraled hard. It kicked off on April 17, when the company shocked the Street by slashing its full-year earnings forecast. This was because a flood of higher-acuity Medicare Advantage patients drove costs far beyond expectations, exposing just how outdated and fragile their forecasting models had become. Then May hit like a wrecking ball. CEO Andrew Witty abruptly resigned, raising eyebrows amid growing pressure. Days later, reports surfaced of a U.S. Department of Justice investigation into alleged Medicare fraud. By mid-May, the stock had crashed, hitting five-year lows. Just when it seemed the damage was done, more scandal dropped with accusations of UnitedHealth secretly paying nursing homes to avoid costly hospital transfers. Even insider buying gave only a brief lift to UNH. In a short span, UnitedHealth went from a rock-solid name to a cautionary tale unraveling in real time. After its brutal springtime plunge, UNH stock is priced at 14 times forward earnings and 0.7 times sales, trading in bargain territory. Those multiples sit well below both the sector medians and its own five-year averages, catching the eye of value hunters sniffing out a possible rebound. Despite the stock's decline, UnitedHealth has signaled some confidence where it counts: dividends. In June, the company hiked its quarterly payout by 5.2% to $2.21, marking 15 consecutive years of increases. Paid out on June 24, the hike pushed its annual yield near 2.6%. On April 17, UnitedHealth reported Q1 2025 earnings, and it wasn't the kind of update Wall Street wanted to hear. Revenue climbed 9.8% year-over-year (YOY) to $109.6 billion but still came in shy of expectations. Adjusted EPS rose 4.2% to $7.20 yet missed the estimated mark of $7.27. UnitedHealthcare, the insurance arm, posted a solid 12.2% revenue gain to $84.6 billion. Meanwhile, Optum saw more modest growth of 4.6% to $63.9 billion, with Optum Rx doing the heavy lifting. Still, rising costs loomed large. Total operating expenses surged 9.4% annually to $100.5 billion. On the brighter side, the company exited the quarter with $34.3 billion in cash and short-term investments and generated $5.5 billion in operating cash flow. Shareholders weren't left in the cold either, with over $5 billion returned through buybacks and dividends. UnitedHealth's steep selloff wasn't just about Q1 results. It was the guidance cut that really rattled sentiment. Management slashed its 2025 adjusted EPS outlook to between $26 and $26.50, down from the initially forecast range of $29.50 to $30 in December 2024 and below fiscal 2024 adjusted EPS of $27.66. Surging Medicare Advantage costs and shifts in Optum's patient mix have taken a real bite. Now, all eyes are on the fiscal Q2 report, expected to be released on July 29 before the market opens. Analysts forecast the Q2 bottom line to be around $5.08 per share, down 25% YOY. Looking to fiscal 2025, adjusted EPS is expected to decline 20% annually to $22.07, then surge by 15% to $25.39 in fiscal 2026. Last Wednesday, UBS reiterated its 'Buy' rating on UNH stock but trimmed the price target to $385 from $400. The cut followed CEO Stephen Hemsley's cautious tone at the June 2 meeting, hinting at more conservative 2025 guidance. UBS anticipates fiscal 2025 EPS closer to $20, down from the earlier $22.50 consensus. Margins were also revised, with Medicare Advantage trimmed to 1.5% and Optum Health lowered to 4.5%. Despite the recent shakeups, Wall Street hasn't completely hit the panic button yet. Last month, UnitedHealth shook things up by axing broker commissions on select Medicare Advantage plans — a move aimed at trimming the cost that forced it to yank full-year guidance. Hightower Chief Investment Strategist Stephanie Link called it a smart pivot, saying the same issue 'got them in trouble' to begin with. Link is bracing for short-term volatility but stays bullish long-term, calling UNH stock 'too cheap' for a top-tier name in the industry. There's still optimism in the air, but with a touch of caution. UNH stock has a 'Moderate Buy' consensus overall, down from a consensus 'Strong Buy' rating a month ago. Of the 24 analysts covering the stock, 15 advise a 'Strong Buy,' two suggest a 'Moderate Buy,' and seven analysts play it safe with a 'Hold.' The mean price target of $363.43 implies shares could rise as much as 18%. The Street-high target of $440, way below this year's highs, signals that UNH has an upside potential of 43% from current levels. The U.S. healthcare industry, despite constant political firestorms, is built to endure. For years, UnitedHealth has stood as its crown jewel. Defensive, dividend-paying, and shock-resistant, it has been the kind of stock long-term investors can count on. But 2025 has shattered that illusion. While the broader market climbs to record highs, UnitedHealth's dramatic plunge reminds us that even giants can stumble hard. Sure, UNH stock now trades at a discount, offering an attractive dividend yield. Insiders are buying shares, and UnitedHealth still commands significant market share and robust cash flow. But is this really a 'buy the dip' moment? It's probably a bet that management can steady the ship, and the storm eventually clears. Until then, UnitedHealth sits in a gray zone between legacy and uncertainty, where long-term promise collides with short-term pain. Investors should exercise caution before jumping in. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Prologis (PLD) To Add 4000 Homes with Caltrain Site Revamp
Prologis (PLD) To Add 4000 Homes with Caltrain Site Revamp

Yahoo

time9 minutes ago

  • Yahoo

Prologis (PLD) To Add 4000 Homes with Caltrain Site Revamp

Prologis, Inc. (NYSE:PLD) is one of the most undervalued stocks. Prologis recently indicated its intention to file redevelopment plans later this year for the Caltrain railyards located at Fourth and King Street. The REIT is proposing a seven-million-square-foot mixed-use project that could accommodate between 1,500 and 4,000 residential units. As reported by the San Francisco Business Times, if fully executed, the development would represent one of the most significant housing initiatives near a major transit corridor in San Francisco. The Business Times noted that the variability in potential housing units offers Prologis the agility to align the project with future demand. Although formal approvals are unlikely before 2027, planning commissioners are already highlighting the importance of affordability. A large logistic facility within the industrial real estate sector. Prologis Vice President Genevieve Cadwalader commented that residential development will be a focal element in the transformation of the railyards into a high-density, transit-oriented urban district. This project holds the potential to be San Francisco's second most densely developed transit-centric neighborhood, following the Transbay district. Prologis, Inc. (NYSE:PLD) is a global REIT focused on high-barrier, high-growth markets in 20 countries. Prologis leases modern logistics facilities to a diverse base of customers across two major categories – business-to-business and retail/online fulfillment. While we acknowledge the potential of PLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store